Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. East Tennessee Clinical Research, Inc
EIR
•East Tennessee Clinical Research, Inc•May 29, 2012

East Tennessee Clinical Research, Inc – FDA EIR, May 29, 2012

Record Details

An FDA inspection of East Tennessee Clinical Research, Inc. (ETCR) was conducted from May 23-29, 2012, focusing on the company's compliance with Good Laboratory Practice (GLP) regulations, specifically concerning a target animal safety study (DOM001). The inspection revealed multiple deficiencies. Key issues included the Quality Assurance Unit (QAU) not being entirely independent of the study's conduct, as required by 21 CFR 58.35(a). The firm also failed to adequately document the testing, calibration, and standardization of laboratory equipment, such as the hematology analyzer, lacking records of quality control checks, expiration dates, and lot numbers for standards (21 CFR 58.63(a)). Furthermore, ETCR lacked proper characterization documentation for the control article (placebo) used in the study (21 CFR 58.105(a)). The QAU failed to monitor contracted laboratory facilities to ensure their compliance with GLP regulations and the study protocol (21 CFR 58.35(a)). Access to the firm's archives was found to be insufficiently controlled, with the existing Standard Operating Procedure (SOP) allowing all employees access during business hours, contrary to regulatory requirements for authorized personnel only (21 CFR 58.190(d)). Lastly, the firm did not consistently maintain a historical file of SOPs with documented routine reviews, failing to adhere to its own internal procedures. Management acknowledged the observations and committed to corrective actions, although specific timelines were not provided.

Company
East Tennessee Clinical Research, Inc
Inspection date
May 29, 2012
Product type
veterinary
Office
New Orleans District Office
People
  • Craig Reinemeyer (company_representative)
  • Daniel L. Aisen (investigator)
  • Ann B. Borromeo (investigator)
View Company Profile

ID · 3e249c10-6792-4276-bdb7-c925b951048b

Violation Codes5
21 CFR 58.35(a)21 CFR 58.63(a)21 CFR 58.105(a)21 CFR 58.90(d)21 CFR 58.81(d)

Full citation text and observation details available on the Dashboard.

Other documents for East Tennessee Clinical Research, Inc
  • 483 - 2023-05-26May 26, 2023
  • EIR - 2014-10-21October 21, 2014
  • 483 - 2014-10-21October 21, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore East Tennessee Clinical Research, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.